glucose, (beta-d)-isomer has been researched along with Diabetes Mellitus Type 1.5 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fourlanos, S; Neoh, SL; Nolan, BJ; Varadarajan, S | 1 |
| Bain, SC; Bashir, J; Chudleigh, R; Nalla, P; Peter, R | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and Diabetes Mellitus Type 1.5
| Article | Year |
|---|---|
Beware Ketoacidosis with SGLT2 Inhibitors in Latent Autoimmune Diabetes of the Adult.
Topics: Aged; Autoantibodies; Benzhydryl Compounds; Diabetic Ketoacidosis; Female; Fluid Therapy; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Ketosis; Latent Autoimmune Diabetes in Adults; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
A case series of DKA occurring in patients receiving treatment with SGLT-2 inhibitors.
Topics: Adult; Aged; Benzhydryl Compounds; Canagliflozin; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Female; Glucosides; Humans; Latent Autoimmune Diabetes in Adults; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors; United Kingdom | 2018 |